lysophosphatidic acid has been researched along with Atypical Ductal Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alemayehu, M; Babwah, AV; Bhattacharya, M; Di Guglielmo, GM; Dragan, M; Pape, C; Sacks, DB; Siddiqui, I | 1 |
1 other study(ies) available for lysophosphatidic acid and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Topics: Apoptosis; Arrestins; beta-Arrestins; Blotting, Western; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Chemotaxis; Female; Humans; Immunoenzyme Techniques; Lysophospholipids; Neoplasm Invasiveness; Neoplasm Staging; ras GTPase-Activating Proteins; Real-Time Polymerase Chain Reaction; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Shelterin Complex; Signal Transduction; Telomere-Binding Proteins | 2013 |